Nitric Oxide for preterm infants
Inhaled nitric oxide (iNO) is a selective pulmonary vasodilator that has demonstrated its efficacy when used to treat severe hypoxemic respiratory failure associated to pulmonary hypertension in term or near term newborns since 1992. Premature newborn infants are not included in the approved indic...
Main Authors: | Manuel Sánchez Luna, Maria Luisa Franco, Elena Zamora, Belén Bernardo |
---|---|
Format: | Article |
Language: | English |
Published: |
Hygeia Press di Corridori Marinella
2013-08-01
|
Series: | Journal of Pediatric and Neonatal Individualized Medicine |
Subjects: | |
Online Access: | https://www.jpnim.com/index.php/jpnim/article/view/74 |
Similar Items
-
Targeted Therapy for Pulmonary Hypertension in Premature Infants
by: Shannon N Nees, et al.
Published: (2020-08-01) -
Inhaled nitric oxide theraphy in preterm infants with severe pulmonary distress syndrome – cases presentation
by: Mihaela Demetrian, et al.
Published: (2020-09-01) -
Diagnostic Approach to Pulmonary Hypertension in Premature Neonates
by: Vasantha H.S. Kumar
Published: (2017-08-01) -
The clinical case of sildenafil administration in a very premature infant with pulmonary hypertension
by: Galina A. Alyamovskaya, et al.
Published: (2015-02-01) -
Bronchopulmonary dysplasia is associated with reduced oral nitrate reductase activity in extremely preterm infants
by: Samuel J. Gentle, et al.
Published: (2021-01-01)